Products for Research Use Only
RegisterLogin

Linifanib (GMP)

CAT: 0804-HY-50751G-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-50751G-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Linifanib (ABT-869) (GMP) is Linifanib produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Linifanib is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRβ, and FLT3, respectively. Linifanib (GMP) promotes the generation and reprogramming of iPSCs from somatic cells[1].
CAS Number
796967-16-3
Product Name Alternative
ABT-869 (GMP) ; AL-39324 (GMP)
UNSPSC
12352005
Hazard Statement
H361, H372, H410
Target
PDGFR; VEGFR
Type
GMP Small Molecules
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/linifanib-gmp.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=C(C2=C3C(N)=NNC3=CC=C2)C=C1)NC4=C(C=CC(C)=C4)F
Molecular Formula
C21H18FN5O
Molecular Weight
375.40
Precautions
H361, H372, H410
References & Citations
[1]Guan J, et al. Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature. 2022 May;605 (7909) :325-331.
Shipping Conditions
Blue Ice
Storage Conditions
Keep sealed and protect from light, store at 2-8°C
Scientific Category
GMP Small Molecules
Clinical Information
No Development Reported

Related Products

CatalogName
HY-50751-01Linifanib
HY-50751SLinifanib-d4
HY-50751RLinifanib (Standard)
HY-N0737AG-01Harmine (GMP)
HY-N0083GBetulin (GMP)
HY-15682G-01TTNPB (GMP)
HY-15794GNemorubicin (GMP)
HY-13506G-01M344 (GMP)
HY-10219G-01Rapamycin (GMP)
HY-107632GGYY4137 (GMP)

Alternative Products

CatalogName
015580Linifanib
CS-B-00298Linifanib-d4
SF5368-5mgLinifanib (VEGFR inhibitor)
E1KS1003Linifanib (ABT-869)

Popular Products